Zantac (Ranitidine) Mass Tort Case Leads
Connect with individuals who developed bladder, stomach, liver, or other cancers after long-term use of Zantac or generic ranitidine contaminated with NDMA.
Zantac Ranitidine Litigation
Zantac (ranitidine), one of the world's most widely used heartburn and acid reflux medications, was found to contain N-Nitrosodimethylamine (NDMA), a probable human carcinogen. The FDA requested manufacturers withdraw all ranitidine products from the market in 2020 after testing confirmed NDMA levels increased over time and with higher storage temperatures. Lawsuits allege manufacturers including Sanofi, Boehringer Ingelheim, and GlaxoSmithKline knew about the NDMA contamination risk and failed to warn consumers.
Associated Conditions
- Bladder cancer
- Stomach cancer (gastric cancer)
- Liver cancer (hepatocellular carcinoma)
- Esophageal cancer
- Pancreatic cancer
- Kidney cancer
- Colorectal cancer
Claimant Eligibility
- Used Zantac or generic ranitidine regularly for six months or longer
- Diagnosed with cancer potentially linked to NDMA exposure
- Purchase records, prescription history, or pharmacy records for ranitidine
- Cancer diagnosis occurred during or after regular Zantac use
- No other primary known cause of the cancer diagnosis
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Zantac legal marketing campaigns: how we acquire cases
Zantac case acquisition runs as a multi-channel program, not a single ad buy. Product liability and class action claimants research their condition long before they contact a lawyer, so we meet potential clients at each stage — paid demand capture for people already searching, paid social and traditional media for people who have not yet connected their injury to the litigation, and organic search for the long research tail.
Digital marketing channels
- Google Ads and paid search demand capture
- Meta and paid social prospecting by exposure profile
- Mass tort search engine optimization for the research tail
- OTT and connected TV retargeting
Traditional media channels
- Broadcast and cable TV in qualifying DMAs
- Radio and streaming audio
- Direct response print in occupational verticals
- Earned media and litigation PR support
How the channel mix is built, budgeted, and measured is covered in our mass tort marketing guide. For intake handling once the lead lands, see mass tort intake.
Running a Zantac mass tort marketing campaign
Common questions from law firms about Zantac lawsuit lead generation and campaign management.
- What does a Zantac mass tort marketing campaign include?
- A Zantac mass tort marketing campaign from Mass Tort Marketing Agency covers multi-channel strategy across Meta, Google PPC, OTT and connected TV, traditional media, and mass tort search engine optimization; compliant ad creative; TCPA-verified intake; claimant qualification against your Zantac case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- How do you generate Zantac mass tort case leads?
- Zantac mass tort case leads are generated through paid social and search campaigns aimed at the specific exposure and injury profile of the litigation, supported by organic content that captures claimants already researching their condition. Every lead is a real, consented claimant — we do not buy aggregated lists or resell shared data.
- What do Zantac legal marketing campaigns cost?
- Zantac legal marketing campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. Cost per retainer varies by tort based on claimant prevalence, media competition, and how tight your case criteria are. We scope a per-tort figure before any spend commitment.
- Are Zantac leads exclusive to my firm?
- Yes. Every Zantac lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Zantac claimants qualified before delivery?
- Each Zantac claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a certified TrustedForm or Jornaya consent record — preserving the exact disclosure language shown at submission — before the lead reaches your intake team.
- How fast can a Zantac case acquisition program scale?
- A Zantac mass tort case acquisition program typically moves from scoping to live media inside two weeks, with volume ramped against your docket capacity rather than pushed to a fixed budget. Volume can be scaled up or down by tort month to month as the litigation posture changes.
Get Zantac campaign pricing on a 30-minute call
We will walk your Zantac case criteria, current cost per signed retainer, and the volume your docket can absorb — and tell you plainly if this tort is not a fit right now.
See how every lead is qualified on our mass tort leads page, read the full mass tort marketing guide, or compare providers in our top mass tort marketing firms guide.